Green Tea Drug Interactions: Iron, EGCG, and What the Research Shows
Most people don't think of green tea as pharmacologically active, and for someone drinking a couple of cups a day, they're largely right. The interaction concerns with green tea are primarily associated with concentrated extract supplements standardized to high EGCG (epigallocatechin gallate) content — the kind marketed for weight loss or antioxidant effects. At those concentrations, EGCG delivers doses far above what food or beverage exposure produces, and at those levels, two interactions are well enough documented to be worth understanding: iron chelation and effects on certain drug transporters.
Iron absorption and catechin chelation
EGCG and other catechins form stable, insoluble complexes with non-heme iron in the gastrointestinal tract. Non-heme iron — the form found in plant foods, fortified foods, and most iron supplements — is already absorbed less efficiently than heme iron from meat, partly because it depends on being in a chemically available form when it reaches absorption sites in the small intestine. When catechins bind to it, they reduce that availability further.
For someone with good iron status eating a varied diet, this chelation from occasional green tea extract use probably has minimal practical consequence. The concern is more significant for people who are iron-deficient or at risk of deficiency — women with heavy periods, pregnant individuals, vegetarians with limited heme iron intake, or anyone taking iron supplementation to correct a deficiency. In those cases, taking green tea extract simultaneously with iron supplements may meaningfully blunt the supplement's effect. NCCIH notes this interaction and the practical fix is simple: separate green tea extract and iron supplements by at least an hour.
Drug transporters and medication levels
EGCG inhibits organic anion transporting polypeptides (OATPs), a class of membrane transporters involved in the intestinal absorption and hepatic uptake of various drugs. The most documented clinical example is nadolol, a beta-blocker used for high blood pressure and certain cardiac conditions. A pharmacokinetic study found that green tea — consumed as a beverage, not just a supplement — reduced nadolol plasma concentrations by roughly 75%, with corresponding reduction in heart rate-lowering effect. The proposed mechanism is OATP1A2 inhibition preventing adequate nadolol absorption.
This is a different mechanism from the cytochrome P450 interactions covered elsewhere on this site. OATPs handle drug uptake; CYP enzymes handle drug metabolism. Both can significantly alter how much of a medication reaches systemic circulation. For nadolol specifically, the green tea interaction is well-characterized. For other OATP substrates — including some statins and certain antivirals — in vitro data suggest similar potential, though clinical studies are limited. NCCIH notes green tea's potential to affect drug metabolism and absorption.
The practical implication is that people taking medications known to use OATP transporters for absorption — nadolol is the clearest example — should not take them at the same time as green tea extract supplements, and ideally should discuss whether high-dose EGCG is appropriate given their medication regimen.